Remove Blog Remove FDA Remove Licensing Remove Regulatory Compliance
article thumbnail

December 2023 Regulatory Compliance Updates

Verisys

– The best resource for monthly healthcare regulatory compliance updates. Rule 402(2) states that when a multistate licensee changes primary states of residence to another NLC party states, they shall apply for a multistate license in the new residence state within 60 days. 01ER ): Effective as a permanent rule on 11/13/2023.

article thumbnail

What is FACIS and Why is it the Gold Standard

Verisys

Excluded from one means excluded from all, and the fines for non-compliance will likely be in the hundreds of thousands. Our FACIS database of more than 10 million records makes it easy to maintain regulatory compliance by identifying red-flag behaviors and trends for any individual you employ from 5,000+ sources. Credentialing.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – July/August

SQA

The counterfeit devices were sold online by a distributor named Healthful Plus without the required license to import, distribute, or sell medical devices in Canada. The packaging of the counterfeit kits resembles authentic (licensed) BTNX Inc. products in color and typeface and uses the BTNX Inc. device identifier “COV-19C25.”

article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

This year’s Drug & Device Law Blog top ten decisions of the year reinforced preemption – the most powerful defense we can assert. Further, the plaintiffs’ arguments were based on scientific standards “not utilized by the FDA,” and thus preempted. The FDA’s five reviews of teratogenic risk all came to the same conclusion.

FDA 105